Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
First 3 Cycles of Treatment	STARTED	Lenalidomide	33
First 3 Cycles of Treatment	Completed 1 Cycle	Lenalidomide	32
First 3 Cycles of Treatment	Started Cycle 2	Lenalidomide	31
First 3 Cycles of Treatment	Completed 3 Cycles	Lenalidomide	26
First 3 Cycles of Treatment	COMPLETED	Lenalidomide	26
First 3 Cycles of Treatment	NOT COMPLETED	Lenalidomide	7
Completed 4 Cycles/Reached 1st Response	STARTED	Lenalidomide	26
Completed 4 Cycles/Reached 1st Response	Completed 4 Cycles/1st Response	Lenalidomide	21
Completed 4 Cycles/Reached 1st Response	COMPLETED	Lenalidomide	21
Completed 4 Cycles/Reached 1st Response	NOT COMPLETED	Lenalidomide	5
Continued Treatment	STARTED	Lenalidomide	21
Continued Treatment	COMPLETED	Lenalidomide	21
Continued Treatment	NOT COMPLETED	Lenalidomide	0
Follow up for a Minimum of 1 Year	STARTED	Lenalidomide	33
Follow up for a Minimum of 1 Year	COMPLETED	Lenalidomide	27
Follow up for a Minimum of 1 Year	NOT COMPLETED	Lenalidomide	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00466921/flow